Cargando…

Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling

Introduction: Overprescribing by providers is a leading contributor to the opioid crisis. Despite available information regarding the role that physician prescribing plays in the community availability of opioids, guidelines for the management of acute pain remain sparse. This project aims to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Knutson, Alex J, Morgan, Brianne M, Feroz, Rehan, Boyd, Sarah S, Stetter, Christy M, Kunselman, Allen R, Long, Jaime B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672922/
https://www.ncbi.nlm.nih.gov/pubmed/34926064
http://dx.doi.org/10.7759/cureus.19595
_version_ 1784615440908025856
author Knutson, Alex J
Morgan, Brianne M
Feroz, Rehan
Boyd, Sarah S
Stetter, Christy M
Kunselman, Allen R
Long, Jaime B
author_facet Knutson, Alex J
Morgan, Brianne M
Feroz, Rehan
Boyd, Sarah S
Stetter, Christy M
Kunselman, Allen R
Long, Jaime B
author_sort Knutson, Alex J
collection PubMed
description Introduction: Overprescribing by providers is a leading contributor to the opioid crisis. Despite available information regarding the role that physician prescribing plays in the community availability of opioids, guidelines for the management of acute pain remain sparse. This project aims to evaluate opioid prescribing, opioid usage patterns, and postoperative pain control in patients undergoing isolated mid-urethral sling (MUS) placement. Methods: Patients who underwent isolated MUS placement from March 19, 2019 through March 19, 2020 were contacted by telephone in May 2020 and asked a series of questions examining opioid usage, postoperative pain, what they did with unused opioids, and whether they had received education on disposal techniques. A chart review was utilized to determine the amount of opioid prescribed, the presence of any operative complications, and medical and demographic characteristics of subjects. Results: A total of 53 subjects met inclusion criteria, of which 31 participated in a phone interview. Of the 53 subjects, 54.7% received a postoperative opioid prescription, and all but two of these subjects filled their prescription. Of the interviewed subjects, only 66.6% who filled a prescription reported using opioids Fifty percent (n=6) of patients that required oxycodone reported use of four tablets (30 morphine milligram equivalents (MMEs)) or less and used for 1-2 days postoperatively. No patient reported using opioids beyond five days. Only 22.2% reported receiving instruction on opioid disposal, and 16.7% returned unused opioids to a disposal center. 87.1% of subjects rated postoperative pain as “better” or “much better” than expected. Conclusion: Patients undergoing isolated MUS placement require limited amounts of postoperative opioids, if any are needed at all, to achieve satisfactory pain control. Excess prescribed opioids, along with inadequate patient education on proper disposal techniques, may contribute towards opioids that are at risk of diversion for nonmedical use.
format Online
Article
Text
id pubmed-8672922
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86729222021-12-16 Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling Knutson, Alex J Morgan, Brianne M Feroz, Rehan Boyd, Sarah S Stetter, Christy M Kunselman, Allen R Long, Jaime B Cureus Obstetrics/Gynecology Introduction: Overprescribing by providers is a leading contributor to the opioid crisis. Despite available information regarding the role that physician prescribing plays in the community availability of opioids, guidelines for the management of acute pain remain sparse. This project aims to evaluate opioid prescribing, opioid usage patterns, and postoperative pain control in patients undergoing isolated mid-urethral sling (MUS) placement. Methods: Patients who underwent isolated MUS placement from March 19, 2019 through March 19, 2020 were contacted by telephone in May 2020 and asked a series of questions examining opioid usage, postoperative pain, what they did with unused opioids, and whether they had received education on disposal techniques. A chart review was utilized to determine the amount of opioid prescribed, the presence of any operative complications, and medical and demographic characteristics of subjects. Results: A total of 53 subjects met inclusion criteria, of which 31 participated in a phone interview. Of the 53 subjects, 54.7% received a postoperative opioid prescription, and all but two of these subjects filled their prescription. Of the interviewed subjects, only 66.6% who filled a prescription reported using opioids Fifty percent (n=6) of patients that required oxycodone reported use of four tablets (30 morphine milligram equivalents (MMEs)) or less and used for 1-2 days postoperatively. No patient reported using opioids beyond five days. Only 22.2% reported receiving instruction on opioid disposal, and 16.7% returned unused opioids to a disposal center. 87.1% of subjects rated postoperative pain as “better” or “much better” than expected. Conclusion: Patients undergoing isolated MUS placement require limited amounts of postoperative opioids, if any are needed at all, to achieve satisfactory pain control. Excess prescribed opioids, along with inadequate patient education on proper disposal techniques, may contribute towards opioids that are at risk of diversion for nonmedical use. Cureus 2021-11-15 /pmc/articles/PMC8672922/ /pubmed/34926064 http://dx.doi.org/10.7759/cureus.19595 Text en Copyright © 2021, Knutson et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Knutson, Alex J
Morgan, Brianne M
Feroz, Rehan
Boyd, Sarah S
Stetter, Christy M
Kunselman, Allen R
Long, Jaime B
Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title_full Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title_fullStr Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title_full_unstemmed Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title_short Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
title_sort opioid prescribing and utilization following isolated mid-urethral sling
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672922/
https://www.ncbi.nlm.nih.gov/pubmed/34926064
http://dx.doi.org/10.7759/cureus.19595
work_keys_str_mv AT knutsonalexj opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT morganbriannem opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT ferozrehan opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT boydsarahs opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT stetterchristym opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT kunselmanallenr opioidprescribingandutilizationfollowingisolatedmidurethralsling
AT longjaimeb opioidprescribingandutilizationfollowingisolatedmidurethralsling